Harshada Adel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Harshada Adel has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Angela Zampella
Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy
1 shared publication - Carmen Festa
Department of Pharmacy University of Naples “Federico II” Via D. Montesano, 49 I‐80131 Naples Italy
1 shared publication - Dorota A. Nawrot
Centre for Drug Research, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, P.O. Box 56, University of Helsinki, Helsinki FI-00014, Finland
1 shared publication - Katja-Emilia Lillsunde
Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5 E (P.O. Box 56), University of Helsinki, FI-00014 Helsinki, Finland
1 shared publication - Lisette D. Souza
CSIR-National Institute of Oceanography, Dona Paula, Goa 403004, India
1 shared publication - Maria Valeria D'Auria
Department of Pharmacy, University of Naples “Federico II”, 80131 Naples, Italy
1 shared publication
Latest Publications
- Open Access
- 3 July 2014
- Published by MDPI AG in Marine Drugs
- Vol. 12 (7) , 4045-4068
Bioactive Cembrane Derivatives from the Indian Ocean Soft Coral, Sinularia kavarattiensis
Marine organisms and their metabolites represent a unique source of potential pharmaceutical substances. In this study, we examined marine-derived substances for their bioactive properties in a cell-based Chikungunya virus (CHIKV) replicon model and for in vitro anti-inflammatory activity. In the screening of a marine sample library, crude extracts from the Indian soft coral, Sinularia kavarattiensis, showed promising activity against the CHIKV replicon. Bioassay-guided chemical fractionation of S. kavarattiensis resulted in the isolation of six known norcembranoids (1–6) and one new compound, named kavaranolide (7). The structures were elucidated on the basis of NMR and MS spectroscopic data. Compounds 1–3 and 5–7 were evaluated for their replicon-inhibiting potential in the CHIKV model by using a luminescence-based detection technique and live cell imaging. Compounds 1 and 2 showed moderate inhibition of the CHIKV replicon, but imaging studies also revealed cytotoxic properties. Moreover, the effects of the isolated compounds on primary microglial cells, an experimental model for neuroinflammation, were evaluated. Compound 2 was shown to modulate the immune response in microglial cells and to possess potential anti-inflammatory properties by dose-dependently reducing the release of pro- and anti-inflammatory cytokines.
- 3 July 2014
- Published by MDPI AG in Marine Drugs
- Vol. 12 (7) , 4045-4068
Open AccessBioactive Cembrane Derivatives from the Indian Ocean Soft Coral, Sinularia kavarattiensis
Marine organisms and their metabolites represent a unique source of potential pharmaceutical substances. In this study, we examined marine-derived substances for their bioactive properties in a cell-based Chikungunya virus (CHIKV) replicon model and for in vitro anti-inflammatory activity. In the screening of a marine sample library, crude extracts from the Indian soft coral, Sinularia kavarattiensis, showed promising activity against the CHIKV replicon. Bioassay-guided chemical fractionation of S. kavarattiensis resulted in the isolation of six known norcembranoids (1–6) and one new compound, named kavaranolide (7). The structures were elucidated on the basis of NMR and MS spectroscopic data. Compounds 1–3 and 5–7 were evaluated for their replicon-inhibiting potential in the CHIKV model by using a luminescence-based detection technique and live cell imaging. Compounds 1 and 2 showed moderate inhibition of the CHIKV replicon, but imaging studies also revealed cytotoxic properties. Moreover, the effects of the isolated compounds on primary microglial cells, an experimental model for neuroinflammation, were evaluated. Compound 2 was shown to modulate the immune response in microglial cells and to possess potential anti-inflammatory properties by dose-dependently reducing the release of pro- and anti-inflammatory cytokines.